Atlas Trials

A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary Hyperparathyroidism

Clinical trial NCT04994080 · UNKNOWN

Trial details

NCT number
NCT04994080
Sponsor
Chengdu Suncadia Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Secondary Hyperparathyroidism
Start date
2022-02-01
Primary completion
2023-03-31
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.